home / openregs

dockets

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

261 rows where agency_id = "DEA" and docket_type = "Rulemaking" sorted by last_modified descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: last_modified (date)

docket_type 1

  • Rulemaking · 261 ✖

agency_id 1

  • DEA · 261 ✖
id agency_id title docket_type last_modified ▲ object_id
DEA_FRDOC_0001 DEA Recently Posted DEA Rules and Notices Rulemaking 2026-03-10T12:55:22Z 0b0000648025b551
DEA-2023-0057 DEA Definition of ‘‘Cannabimimetic Agents’’ and Assignment of an Administration Controlled Substances Code Number for All ‘‘Cannabimimetic Agents’’ (DEA368) Rulemaking 2026-01-20T18:44:45Z 0b00006485945c83
DEA-2026-0133 DEA Schedules of Controlled Substances: Placement of 2-Fluorodeschloroketamine in Schedule I (DEA1442) Rulemaking 2026-01-20T18:39:12Z 0b000064b9161bed
DEA-2025-0075 DEA Placement of 4-Fluoroamphetamine in Schedule I (DEA1180) Rulemaking 2026-01-16T15:16:59Z 0b000064b8dc49a1
DEA-2023-0029 DEA Telemedicine Prescribing of Controlled Substances (DEA407) Rulemaking 2026-01-12T22:00:12Z 0b00006485728671
DEA-2024-0118 DEA Schedules of Controlled Substances: Temporary Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I (DEA1337) Rulemaking 2026-01-12T21:58:59Z 0b00006486732eab
DEA-2023-0147 DEA Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I (DEA1143) Rulemaking 2026-01-05T20:10:17Z 0b0000648613cdb2
DEA-2025-0852 DEA Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I (DEA1511) Rulemaking 2026-01-05T13:16:32Z 0b000064b90c539c
DEA-2025-0918 DEA Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I of the Controlled Substances Act (DEA1604) Rulemaking 2026-01-05T13:16:18Z 0b000064b90dd26c
DEA-2025-0654 DEA Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2026 Rulemaking 2025-12-16T20:07:46Z 0b000064b909f13a
DEA-2025-0885 DEA Schedules of Controlled Substances: Placement of Bromazolam in Schedule I (DEA1420) Rulemaking 2025-12-15T15:47:54Z 0b000064b90d3674
DEA-2025-0555 DEA Schedules of Controlled Substances: Placement of MDMB-4-PINACA in Schedule I (DEA1356) Rulemaking 2025-12-11T14:41:46Z 0b000064b8fefe20
DEA-2024-0144 DEA Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I (DEA1246) Rulemaking 2025-11-19T21:13:12Z 0b00006486891ffe
DEA-2025-0557 DEA Designation of P2P Methyl Glycidic Acid as a List I Chemical (DEA1395) Rulemaking 2025-11-04T12:07:45Z 0b000064b8fefe8d
DEA-2025-0588 DEA Schedules of Controlled Substances: Temporary Placement of ethyleneoxynitazene, methylenedioxynitazene, 5-methyl etodesnitazene, N-desethyl etonitazene, N-desethyl protonitazene, N,N-dimethylamino etonitazene, and N-pyrrolidino isotonitazene in Schedule I (DEA1494) Rulemaking 2025-10-16T23:33:17Z 0b000064b9030281
DEA-2025-0192 DEA Specific Listing for Dipentylone, a Currently Controlled Schedule I Substance (DEA1390) Rulemaking 2025-10-16T23:28:47Z 0b000064b8ec6630
DEA-2023-0016 DEA Controlled Substances Ordering System Modernization (DEA732) Rulemaking 2025-10-02T21:31:46Z 0b0000648562ccb3
DEA-2025-0558 DEA Requiring Online Submission of Applications for and Renewals of DEA Registration; Correction (DEA1111) Rulemaking 2025-10-02T21:30:04Z 0b000064b8fefe93
DEA-2024-0148 DEA Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I of the Controlled Substances Act (DEA1457) Rulemaking 2025-10-02T21:28:47Z 0b00006486894bb0
DEA-2025-0556 DEA Specific Listing for 1-boc-4-piperidone, a Currently Controlled List I Chemical Rulemaking 2025-10-02T21:22:21Z 0b000064b8fefe24
DEA-2024-0120 DEA Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2025 Rulemaking 2025-09-19T16:15:52Z 0b00006486783c5d
DEA-2022-0145 DEA Schedules of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I (DEA989) Rulemaking 2025-08-27T12:33:24Z 0b0000648554cfe6
DEA-2024-0026 DEA Placement of 2-Methyl AP-237 in Schedule I (DEA1245) Rulemaking 2025-07-28T18:22:10Z 0b00006486484632
DEA-2023-0148 DEA Destruction Alternatives to Incineration (DEA1144) Rulemaking 2025-07-28T18:21:23Z 0b0000648618d50c
DEA-2025-0078 DEA Three specific fentanyl-related substances (para-bromofentanyl, para-fluoroacetyl fentanyl, and para-methyl acetyl fentanyl) (DEA1484) Rulemaking 2025-07-28T18:18:20Z 0b000064b8dd586c
DEA-2023-0138 DEA Designation of Propionyl Chloride as a List I Chemical (DEA1189) Rulemaking 2025-07-10T12:04:03Z 0b000064860bbba7
DEA-2025-0081 DEA Placement of 3-methoxyphencyclidine (1-[1-(3-methoxyphenyl)cyclohexyl] piperidine) in Schedule I (DEA1146) Rulemaking 2025-07-10T11:56:30Z 0b000064b8ddd142
DEA-2023-0098 DEA Implementation of the Designer Anabolic Steroid Control Act of 2014 (DEA481) Rulemaking 2025-07-07T16:45:39Z 0b00006485d9c470
DEA-2021-0003 DEA Suspicious Orders of Controlled Substances Rulemaking 2025-06-05T16:32:03Z 0b000064849e1a2e
DEA-2023-0028 DEA Expansion of Induction of Buprenorphine via Telemedicine Encounter (DEA948) Rulemaking 2025-06-02T20:11:54Z 0b0000648572859f
DEA-2024-0059 DEA Schedules of Controlled Substances: Rescheduling of Marijuana Rulemaking 2025-02-21T15:51:02Z 0b0000648656cd99
DEA-2023-0168 DEA Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I (DEA1156) Rulemaking 2025-02-21T15:50:53Z 0b00006486330ce3
DEA-2023-0150 DEA Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2024 (DEA1228) Rulemaking 2025-02-21T15:50:43Z 0b000064861df091
DEA-2024-0134 DEA Control of Phenethyl Bromide as a List I Chemical (DEA1282) Rulemaking 2025-01-07T09:13:06Z 0b0000648683d06e
DEA-2021-0031 DEA Schedules of Controlled Substances: Temporary Placement of Butonitazene, Etodesnitazene, Flunitazene, Metodesnitazene, Metonitazene, N-pyrrolidino etonitazene, and Protonitazene in Schedule I Rulemaking 2024-10-25T14:56:30Z 0b00006484ea7ed9
DEA-2023-0129 DEA Placement of Ethylphenidate in Schedule I (DEA1142) Rulemaking 2024-10-24T10:27:34Z 0b00006485fe80fd
DEA-2023-0149 DEA Placement of Zuranolone in Schedule IV (DEA1258) Rulemaking 2024-09-03T18:47:04Z 0b000064861a0975
DEA-2022-0058 DEA Providing CS to Ocean Vessels, Aircraft, and Other Entities Rulemaking 2024-08-26T13:13:33Z 0b0000648514e942
DEA-2024-0009 DEA Conforming Amendment Regarding the Veterinary Medicine Mobility Act of 2014 Rulemaking 2024-08-26T13:13:33Z 0b000064863e8464
DEA-2021-0027 DEA Regulation of Telepharmacy Practice Rulemaking 2024-08-26T13:06:55Z 0b00006484e57207
DEA-2020-0023 DEA Implementation of the Agricultural Improvement Act Rulemaking 2024-08-26T13:03:33Z 0b0000648481bb3b
DEA-2020-0031 DEA Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment Rulemaking 2024-08-26T13:03:21Z 0b00006484946331
DEA-2020-0029 DEA Registering Emergency Medical Services Agencies under the Protecting Patient Access to Emergency Medications Act of 2017 Rulemaking 2024-08-26T13:02:59Z 0b000064848b8dbc
DEA-2010-0010 DEA Electronic Prescriptions for Controlled Substances Rulemaking 2024-08-26T13:00:45Z 0b00006480acce59
DEA-2021-0005 DEA Amending Regulations to Require Online Submission of Applications for and Renewals of DEA Registration Rulemaking 2024-07-12T12:24:57Z 0b000064849e58a9
DEA-2021-0009 DEA MAPA - Designation as List I Chemical: Methyl alpha-phenylacetoacetate, a Precursor Chemical Used in the Illicit Manufacture of Phenylacetone, Methamphetamine, and Amphetamine Rulemaking 2024-06-11T01:13:26Z 0b00006484aeb507
DEA-2022-0120 DEA Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2023 Rulemaking 2024-02-12T10:32:02Z 0b000064854169b8
DEA-2023-0169 DEA Specific Listing for Three Currently Controlled Schedule I Substances (DEA1222) Rulemaking 2024-02-12T10:29:05Z 0b00006486330ce7
DEA-2023-0049 DEA Temporary Placement of MDMB-4en-PINACA, 4F-MDMB-BUTICA, ADB-4en-PINACA, CUMYL-PEGACLONE, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I (DEA1006) Rulemaking 2023-12-12T10:13:43Z 0b000064858c4370
DEA-2023-0058 DEA Placement of Nine Specific Fentanyl Related Substances in Schedule I (DEA1036) Rulemaking 2023-12-07T08:20:24Z 0b00006485946204
DEA-2023-0146 DEA Additions to Listing of Exempt Chemical Mixtures (DEA1118) Rulemaking 2023-11-28T08:25:33Z 0b00006486128852
DEA-2023-0059 DEA Designation as List I Chemicals: Halides of 4-Anilinopiperidine (DEA1098) Rulemaking 2023-10-31T09:33:44Z 0b00006485948761
DEA-2023-0106 DEA Dispensing of Narcotic Drugs to Relieve Acute Withdrawal Symptoms of Opioid Use Disorder (DEA702) Rulemaking 2023-09-22T15:24:15Z 0b00006485e04d45
DEA-2019-0013 DEA Management of Quotas for Controlled Substances and List I Chemicals Rulemaking 2023-08-31T08:33:18Z 0b000064840ecddb
DEA-2021-0026 DEA Transfer of Electronic Prescriptions for Controlled Substances for Initial Filling Rulemaking 2023-07-27T17:35:24Z 0b00006484e3d5e0
DEA-2020-0035 DEA Partial Filling of Prescriptions for Schedule II Controlled Substances Rulemaking 2023-07-21T08:48:17Z 0b0000648498d6d9
DEA-2020-0038 DEA Schedules of Controlled Substances: Placement of Brorphine in Schedule I Rulemaking 2023-07-19T11:16:28Z 0b000064849c2716
DEA-2020-0022 DEA Reporting of Theft or Significant Loss of Controlled Substances Rulemaking 2023-06-22T11:34:57Z 0b000064847f5109
DEA-2023-0056 DEA Specific Listing for Eutylone, a Currently Controlled Schedule I Substance (DEA1003) Rulemaking 2023-04-20T11:59:12Z 0b0000648591cd29
DEA-2022-0102 DEA Designation of 4-Piperidone as a List I Chemical (DEA951) Rulemaking 2023-04-14T08:25:52Z 0b0000648532a5f2
DEA-2021-0013 DEA Schedules of Controlled Substances: Placement of Methiopropamine in Schedule I Rulemaking 2023-01-03T10:35:25Z 0b00006484d9d986
DEA-2022-0137 DEA Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2023 Rulemaking 2022-12-02T09:49:04Z 0b00006485511272
DEA-2020-0027 DEA Default Provisions for Hearing Proceedings Relating to the Revocation, Suspension, or Denial of a Registration Rulemaking 2022-11-30T08:08:19Z 0b000064848ac79e
DEA-2021-0012 DEA Schedules of Controlled Substances: Placement of Mesocarb in Schedule I Rulemaking 2022-11-22T08:27:38Z 0b00006484c6c390
DEA-2021-0025 DEA Schedules of Controlled Substances: Removal of [18F]FP-CIT from Control Rulemaking 2022-11-21T08:32:10Z 0b00006484e16b15
DEA-2020-0015 DEA Schedules of Controlled Substances: Placement of Zipeprol in Schedule I Rulemaking 2022-11-21T08:31:59Z 0b000064846acf98
DEA-2021-0011 DEA Schedules of Controlled Substances: Placement of Amineptine in Schedule I Rulemaking 2022-11-17T08:07:18Z 0b00006484c12765
DEA-2022-0134 DEA Specific Listing for 1-boc-4-AP, a Currently Controlled List I Chemical (DEA1046) Rulemaking 2022-11-14T08:34:19Z 0b0000648549e00d
DEA-2022-0133 DEA Technical Correction to Regulation Regarding Registration Exception for Officials Rulemaking 2022-11-07T09:10:13Z 0b000064854931e9
DEA-2021-0014 DEA Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2022 Rulemaking 2022-11-01T08:26:20Z 0b00006484dc7d4f
DEA-2022-0025 DEA Schedules of Controlled Substances: Placement of Daridorexant in Schedule IV Rulemaking 2022-09-30T08:21:23Z 0b00006484fff734
DEA-2022-0026 DEA Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I Rulemaking 2022-09-13T08:49:45Z 0b0000648500a875
DEA-2022-0001 DEA Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine, 5-methoxy-alpha-methyltryptamine, 5-methoxy-N-methyl-N-isopropyltryptamine, 5-methoxy-N,N-diethyltryptamine, and N,N-diisopropyltryptamine in Schedule I Rulemaking 2022-07-27T08:21:18Z 0b00006484f21216
DEA-2021-0010 DEA Schedules of Controlled Substances: Placement of Serdexmethylphenidate in Schedule IV Rulemaking 2022-06-24T08:22:18Z 0b00006484b1ab60
DEA-2022-0027 DEA Schedules of Controlled Substances: Exempted Prescription Products - Butalbital products Rulemaking 2022-06-07T08:46:48Z 0b0000648500f7d4
DEA-2021-0030 DEA Schedules of Controlled Substances: Placement of Methoxetamine in Schedule I Rulemaking 2022-06-06T09:58:53Z 0b00006484ea7ed5
DEA-2019-0002 DEA Schedules of Controlled Substances: Placement of 5F-EDMBPINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 in Schedule I Rulemaking 2022-04-08T08:28:19Z 0b00006483b714a4
DEA-2018-0002 DEA Implementation of the Provision of the Comprehensive Addiction and Recovery Act of 2016 Relating to the Dispensing of Narcotic Drugs for Opioid Use Disorder Rulemaking 2022-04-02T01:07:02Z 0b00006482e4b773
DEA-2018-0009 DEA Schedules of Controlled Substances: Placement of beta-Hydroxythiofentanyl into Schedule I Rulemaking 2022-04-02T01:07:02Z 0b00006483254c72
DEA-2014-0005 DEA Schedules of Controlled Substances: Rescheduling of Hydrocodone Combination Products from Schedule III to Schedule II Rulemaking 2022-03-22T11:18:07Z 0b000064815b6cb3
DEA-2018-0004 DEA Schedules of Controlled Substances: Placement of Butyryl Fentanyl and U–47700 Into Schedule I (DEA-478) Rulemaking 2022-03-22T11:16:58Z 0b0000648319a695
DEA-2021-0024 DEA Adding Space Force to DEA Regulations Rulemaking 2021-12-13T15:38:43Z 0b00006484e0408e
DEA-2020-0036 DEA Supplier's Registration Number on the Single-Sheet DEA Form 222 Rulemaking 2021-12-13T15:35:55Z 0b000064849af553
DEA-2020-0005 DEA Registration Requirements for Narcotic Treatment Programs with Mobile Components Rulemaking 2021-12-13T15:33:40Z 0b000064843b54e5
DEA-2013-0002 DEA Schedules of Controlled Substances: Placement of Alfaxalone into Schedule IV Rulemaking 2021-12-02T01:01:29Z 0b000064812438ed
DEA-2013-0009 DEA Schedules of Controlled Substances: Placement of Perampanel into Schedule III Rulemaking 2021-12-02T01:01:29Z 0b000064814577a1
DEA-2013-0010 DEA Schedules of Controlled Substances: Placement of Tramadol into Schedule IV Rulemaking 2021-12-02T01:01:29Z 0b0000648146f62c
DEA-2013-0011 DEA Schedules of Controlled Substances: Temporary Placement of Three Synthetic Phenethylamines into Schedule I Rulemaking 2021-12-02T01:01:29Z 0b0000648147da34
DEA-2018-0006 DEA Schedules of Controlled Substances: Extension of Temporary Placement of Five Synthetic Cannabinoids Into Schedule I of the Controlled Substances Act, DEA-345 Rulemaking 2021-12-02T01:01:29Z 0b0000648321a7cd
DEA-2019-0007 DEA Schedules of Controlled Substances: Removal of 6-beta-Naltrexol from Control Rulemaking 2021-12-02T01:01:29Z 0b00006483eaf996
DEA-2019-0003 DEA Interlocutory Appeals in Administrative Hearings Rulemaking 2021-12-02T01:00:59Z 0b00006483c17ccc
DEA-2019-0004 DEA Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone, a-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-a-PVP in Schedule I Rulemaking 2021-12-02T01:00:59Z 0b00006483c8ada8
DEA-2019-0009 DEA Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone, a-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-a-PVP in Schedule I Rulemaking 2021-12-02T01:00:59Z 0b00006483f91d72
DEA-2019-0010 DEA Listing of Noroxymorphone in the Code of Federal Regulations and Assignment of a Controlled Substances Code Number Rulemaking 2021-12-02T01:00:59Z 0b00006483f94f85
DEA-2019-0011 DEA Schedules of Controlled Substances: Designation of Benzylfentanyl and 4-Anilinopiperidine, Precursor Chemicals Used in the Illicit Manufacture of Fentanyl, as List I Chemicals Rulemaking 2021-12-02T01:00:59Z 0b00006483f94f89
DEA-2019-0012 DEA Schedules of Controlled Substances: Control of the Immediate Precursor Norfentanyl Used in the Illicit Manufacture of Fentanyl as Schedule II Rulemaking 2021-12-02T01:00:59Z 0b00006483f94f8d
DEA-2019-0014 DEA Schedules of Controlled Substances: Placement of Cyclopropyl Fentanyl, Methoxyacetyl fentanyl, ortho-Fluorofentanyl, and para-Fluorobutyryl Fentanyl in Schedule I Rulemaking 2021-12-02T01:00:59Z 0b000064841fc599
DEA-2020-0004 DEA Schedules of Controlled Substances: Removal of 6-beta-Naltrexol from Control Rulemaking 2021-12-02T01:00:59Z 0b00006484322c50
DEA-2020-0014 DEA Technical Correction to Regulation Regarding Registration Rulemaking 2021-12-02T01:00:59Z 0b000064844bd097
DEA-2020-0017 DEA Schedules of Controlled Substances: Placement of Isotonitazene in Schedule I Rulemaking 2021-12-02T01:00:59Z 0b000064846f9f29

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE dockets (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    title TEXT,
    docket_type TEXT,
    last_modified TEXT,
    object_id TEXT
);
CREATE INDEX idx_dockets_agency ON dockets(agency_id);
CREATE INDEX idx_dockets_type ON dockets(docket_type);
Powered by Datasette · Queries took 80.786ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API